Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate

J Virol. 2010 Jan;84(1):492-502. doi: 10.1128/JVI.01743-09.

Abstract

Human immunodeficiency virus (HIV)-infected infants in the developing world typically progress to AIDS or death within the first 2 years of life. However, a minority progress relatively slowly. This study addresses the potential contribution of viral factors to HIV disease progression in eight infants selected from a well-characterized cohort of C clade HIV-infected infants, monitored prospectively from birth in Durban, South Africa. Three infants were defined as "progressors," and five were defined as "slow progressors." We observed that slow-progressor infants carry HIV isolates with significantly lower replicative capacity compared to virus from progressors. Furthermore, our data suggest a link between the attenuated viral phenotype and HLA-B* 57/5801 epitope-specific Gag mutational patterns of the transmitted virus and not to coreceptor usage or to the presence of Nef deletions or insertions. These data underline the importance of virus-host interactions and highlight the contribution of viral attenuation through Gag-specific CD8(+) T-cell escape mutations, among other factors, in the control of pediatric HIV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD8-Positive T-Lymphocytes / immunology
  • Cohort Studies
  • Disease Progression
  • Gene Products, gag / genetics*
  • Gene Products, gag / immunology
  • HIV Infections / transmission*
  • HIV-1 / genetics
  • HIV-1 / physiology*
  • HLA-B Antigens / immunology
  • Host-Pathogen Interactions
  • Humans
  • Immune Evasion / genetics*
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical*
  • Kinetics
  • Mutation
  • South Africa
  • Virus Replication*

Substances

  • Gene Products, gag
  • HLA-B Antigens
  • HLA-B*58:01 antigen
  • HLA-B57 antigen